Literature DB >> 33436830

Anti-proliferative and anti-migratory properties of coffee diterpenes kahweol acetate and cafestol in human renal cancer cells.

Tomoyuki Makino1, Kouji Izumi2, Kaoru Hiratsuka1, Hiroshi Kano1, Takashi Shimada1, Taito Nakano1, Suguru Kadomoto1, Renato Naito1, Hiroaki Iwamoto1, Hiroshi Yaegashi1, Kazuyoshi Shigehara1, Yoshifumi Kadono1, Hiroki Nakata3, Yohei Saito4, Kyoko Nakagawa-Goto4, Norihiko Sakai5, Yasunori Iwata5, Takashi Wada5, Atsushi Mizokami1.   

Abstract

Despite improvements in systemic therapy options for renal cancer, it remains one of the most drug-resistant malignancies. Interestingly, reports have shown that kahweol and cafestol, natural diterpenes extracted from coffee beans, exhibit anti-cancer activity. However, the multiple potential pharmacological actions of both have yet to be fully understood. This study therefore investigated the effects of kahweol acetate and cafestol on human renal cancer ACHN and Caki-1 cells. Accordingly, the combination of kahweol acetate and cafestol administration synergistically inhibited cell proliferation and migration by inducing apoptosis and inhibiting epithelial-mesenchymal transition. Mechanistic dissection revealed that kahweol acetate and cafestol inhibited Akt and ERK phosphorylation. Moreover, kahweol acetate and cafestol downregulated the expression of not only C-C chemokine receptors 2, 5, and 6 but also programmed death-ligand 1, indicating their effects on the tumor microenvironment. Thus, kahweol acetate and cafestol may be novel therapeutic candidates for renal cancer considering that they exert multiple pharmacological effects.

Entities:  

Year:  2021        PMID: 33436830      PMCID: PMC7804192          DOI: 10.1038/s41598-020-80302-4

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  47 in total

Review 1.  The STATs of cancer--new molecular targets come of age.

Authors:  Hua Yu; Richard Jove
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

2.  Autocrine MCP-1/CCR2 signaling stimulates proliferation and migration of renal carcinoma cells.

Authors:  Christoph Küper; Franz-Xaver Beck; Wolfgang Neuhofer
Journal:  Oncol Lett       Date:  2016-07-18       Impact factor: 2.967

3.  Coffee consumption protects human lymphocytes against oxidative and 3-amino-1-methyl-5H-pyrido[4,3-b]indole acetate (Trp-P-2) induced DNA-damage: results of an experimental study with human volunteers.

Authors:  J Bichler; C Cavin; T Simic; A Chakraborty; F Ferk; C Hoelzl; R Schulte-Hermann; M Kundi; G Haidinger; K Angelis; S Knasmüller
Journal:  Food Chem Toxicol       Date:  2007-02-12       Impact factor: 6.023

4.  Role of CCL20/CCR6 and the ERK signaling pathway in lung adenocarcinoma.

Authors:  Xiao-Peng Zhang; Zhi-Juan Hu; Ai-Hong Meng; Guo-Chen Duan; Qing-Tao Zhao; Jing Yang
Journal:  Oncol Lett       Date:  2017-10-23       Impact factor: 2.967

5.  The coffee diterpene kahweol sensitizes TRAIL-induced apoptosis in renal carcinoma Caki cells through down-regulation of Bcl-2 and c-FLIP.

Authors:  Hee Jung Um; Jung Hwa Oh; Yoon-Nyun Kim; Yung Hyun Choi; Sang Hyun Kim; Jong-Wook Park; Taeg Kyu Kwon
Journal:  Chem Biol Interact       Date:  2010-04-18       Impact factor: 5.192

6.  Anti-Angiogenic Properties of Cafestol and Kahweol Palmitate Diterpene Esters.

Authors:  Marzieh Moeenfard; Alice Cortez; Vera Machado; Raquel Costa; Carla Luís; Pedro Coelho; Raquel Soares; Arminda Alves; Nuno Borges; Alejandro Santos
Journal:  J Cell Biochem       Date:  2016-05-08       Impact factor: 4.429

7.  Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.

Authors:  Robert J Motzer; Bernard Escudier; David F McDermott; Saby George; Hans J Hammers; Sandhya Srinivas; Scott S Tykodi; Jeffrey A Sosman; Giuseppe Procopio; Elizabeth R Plimack; Daniel Castellano; Toni K Choueiri; Howard Gurney; Frede Donskov; Petri Bono; John Wagstaff; Thomas C Gauler; Takeshi Ueda; Yoshihiko Tomita; Fabio A Schutz; Christian Kollmannsberger; James Larkin; Alain Ravaud; Jason S Simon; Li-An Xu; Ian M Waxman; Padmanee Sharma
Journal:  N Engl J Med       Date:  2015-09-25       Impact factor: 91.245

Review 8.  Prognostic factors and prognostic models for renal cell carcinoma: a literature review.

Authors:  Tobias Klatte; Sabrina H Rossi; Grant D Stewart
Journal:  World J Urol       Date:  2018-04-30       Impact factor: 4.226

Review 9.  Targeting the PD-1/PD-L1 Pathway in Renal Cell Carcinoma.

Authors:  Solène-Florence Kammerer-Jacquet; Antoine Deleuze; Judikaël Saout; Romain Mathieu; Brigitte Laguerre; Gregory Verhoest; Frédéric Dugay; Marc-Antoine Belaud-Rotureau; Karim Bensalah; Nathalie Rioux-Leclercq
Journal:  Int J Mol Sci       Date:  2019-04-04       Impact factor: 5.923

Review 10.  Cafestol and Kahweol: A Review on Their Bioactivities and Pharmacological Properties.

Authors:  Yaqi Ren; Chunlan Wang; Jiakun Xu; Shuaiyu Wang
Journal:  Int J Mol Sci       Date:  2019-08-30       Impact factor: 5.923

View more
  3 in total

Review 1.  Therapeutic Potential of Natural Products in the Treatment of Renal Cell Carcinoma: A Review.

Authors:  Chenchen Feng; Yinfeng Lyu; Lingxiao Gong; Jing Wang
Journal:  Nutrients       Date:  2022-05-28       Impact factor: 6.706

Review 2.  Epidemiology and Prevention of Renal Cell Carcinoma.

Authors:  Tomoyuki Makino; Suguru Kadomoto; Kouji Izumi; Atsushi Mizokami
Journal:  Cancers (Basel)       Date:  2022-08-22       Impact factor: 6.575

Review 3.  A Decade of Research on Coffee as an Anticarcinogenic Beverage.

Authors:  Ayelén D Nigra; Anderson J Teodoro; Germán A Gil
Journal:  Oxid Med Cell Longev       Date:  2021-09-15       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.